Abstract
Purpose
To compare the visualization of microaneurysms (MAs) in patients with diabetic retinopathy (DR) using optical coherence tomography angiography (OCTA) with that using fluorescein angiography (FA).
Study design
Prospective, clinical, and experimental.
Methods
This study was a prospective evaluation of imaging technology. Thirty-seven eyes of 33 patients with DR were scanned using an OCTA instrument. The 83 MAs that were confirmed on OCT B-scan and OCT en face images were evaluated using OCTA, and these findings were compared with those evaluated using FA.
Results
Of the 83 MAs confirmed on OCT B-scan images, 73 (88%) were clearly visualized on the OCTA en face images as nodular or comma-shaped structures, while the remaining 12% did not present with a typical MA or vascular structure on the OCTA en face images at the relevant positions. Seventy-four of the 83 MAs (87%) confirmed on the OCT B-scan images presented as punctate hyperfluorescent spots on the FA images. On the FA images, 8 of 9 (88%) MAs absent on the OCTA en face images presented as hyperfluorescent spots. Visualization of the MAs on the OCTA en face images did not correlate with the OCT B-scan images of the MA lumens (open, closed, or heterogeneous).
Conclusions
For diabetic maculopathy, OCTA en face images do not present with comprehensive MAs images, indicating that some MAs might be overlooked with OCTA en face images.
Similar content being viewed by others
Change history
24 February 2018
In the original publication, the yellow circles in Figures 2a, 2b, 3a and 3b are placed incorrectly. The corrected figures are given in this Erratum.
References
Yeung L, Lima VC, Garcia P, Landa G, Rosen RB. Correlation between spectral domain optical coherence tomography findings and fluorescein angiography patterns in diabetic macular edema. Ophthalmology. 2009;116:1158–67.
Huang Y, Zhang Q, Thorell MR, An L, Durbin MK, Laron M, et al. Swept-source OCT angiography of the retinal vasculature using intensity differentiation-based optical microangiography algorithms. Ophthalmic Surg Lasers Imaging Retina. 2014;45:382–9.
Ishibazawa A, Nagaoka T, Takahashi A, Omae T, Tani T, Sogawa K, et al. Optical coherence tomography angiography in diabetic retinopathy: a prospective pilot study. Am J Ophthalmol. 2015;160:35–44.
Jia Y, Tan O, Tokayer J, Potsaid B, Wang Y, Liu JJ, et al. Split-spectrum amplitude correlation angiography with optical coherence tomography. Opt Express. 2012;20:4710–25.
Jia Y, Bailey ST, Wilson DJ, Tan O, Klein ML, Flaxel CJ, et al. Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration. Ophthalmology. 2014;121:1435–44.
Jia Y, Wei E, Wang X, Zhang X, Morrison JC, Parikh M, et al. Optical coherence tomography angiography of optic disc perfusion in glaucoma. Ophthalmology. 2014;121:1322–32.
Mariampillai A, Standish BA, Moriyama EH, Khurana M, Munce NR, Leung MK, et al. Speckle variance detection of microvasculature using swept-source optical coherence tomography. Opt Lett. 2008;33:1530–2.
Miura M, Makita S, Iwasaki T, Yasuno Y. Three-dimensional visualization of ocular vascular pathology by optical coherence angiography in vivo. Invest Ophthalmol Vis Sci. 2011;52:2689–95.
Miura M, Hong YJ, Yasuno Y, Muramatsu D, Iwasaki T, Goto H. Three-dimensional vascular imaging of proliferative diabetic retinopathy by Doppler optical coherence tomography. Am J Ophthalmol. 2015;159:528–38.
Schwartz DM, Fingler J, Kim DY, Zawadzki RJ, Morse LS, Park SS, et al. Phase-variance optical coherence tomography: a technique for noninvasive angiography. Ophthalmology. 2014;121:180–7.
Spaide RF, Klancnik JM Jr, Cooney MJ. Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. JAMA Ophthalmol. 2015;133:45–50.
Cheng S, Leng T. Noninvasive detection of microaneurysms in diabetic retinopathy by swept-source optical coherence tomography. Clin Ophthalmol. 2016;16:1791–5.
Miwa Y, Murakami T, Suzuma K, Uji A, Yoshitake S, Fujimoto M, et al. Relationship between functional and structural changes in diabetic vessels in optical coherence tomography angiography. Sci Rep. 2016;6:29064.
Salz DA, de Carlo TE, Adhi M, Moult E, Choi W, Baumal CR, et al. Select features of diabetic retinopathy on swept-source optical coherence tomographic angiography compared with fluorescein angiography and normal eyes. JAMA Ophthalmol. 2016;1:644–50.
Parravano M, De Geronimo D, Scarinci F, Querques L, Virgili G, Simonett JM, et al. Relationship between internal reflectivity of diabetic microaneurysms on SD-OCT and detection on OCT angiography. Am J Ophthalmol. 2017;179:90–6.
Couturier A, Mané V, Bonnin S, Erginay A, Massin P, Gaudric A, et al. Capillary plexus anomalies in diabetic retinopathy on optical coherence tomography angiography. Retina. 2015;35:2384–91.
Horii T, Murakami T, Nishijima K, Sakamoto A, Ota M, Yoshimura N. Optical coherence tomographic characteristic of microaneurysms in diabetic retinopathy. Am J Ophthalmol. 2009;150:840–8.
Hellstedt T, Immonen I. Disappearance and formation rates of microaneurysms in early diabetic retinopathy. Br J Ophthalmol. 1996;80:135–9.
Jalli PY, Hellstedt TJ, Immonen IJ. Early versus late staining of microaneurysms in fluorescein angiography. Retina. 1997;17:211–5.
Stitt AW, Gardiner TA, Archer DB. Histological and ultrastructural investigation of retinal microaneurysm development in diabetic patients. Br J Ophthalmol. 1995;79:362–7.
Moore J, Bagley S, Ireland G, McLeod D, Boulton ME. Three dimensional analysis of microaneurysms in the human diabetic retina. J Anat. 1999;194:89–100.
Tam J, Dhamdhere KP, Tiruveedhula P, et al. Subclinical capillary changes in non-proliferative diabetic retinopathy. Optom Vis Sci. 2012;89:E692–703.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
M. Hamada, Equipment (Chuo Sangio); K. Ohkoshi, Equipment (Chuo Sangio); K. Inagaki, Nnoe; N. Ebihara, None; A. Murakami, Grant (Abbott Japan, Alcon Japan, Eisai, HOYA, Kaken Pharmaceutical, Kowa Pharmaceutical, Lumenis, MSD, Novartis Phama, Otsuka Pharmaceutical, Pfizer Japan, Santen Pharmaceutical, SEED, Senju Pharmaceutical, Rohto Pharmaceutical, Wakamoto), P (The license for hydrogel ophthalmic lens for gene therapy of eye was acquired by SEED from the Author).
Additional information
The original version of this article was revised: In the original publication, the yellow circles in Figures 2a, 2b, 3a and 3b were placed incorrectly. The figures are corrected.
A correction to this article is available online at https://doi.org/10.1007/s10384-018-0577-6.
About this article
Cite this article
Hamada, M., Ohkoshi, K., Inagaki, K. et al. Visualization of microaneurysms using optical coherence tomography angiography: comparison of OCTA en face, OCT B-scan, OCT en face, FA, and IA images. Jpn J Ophthalmol 62, 168–175 (2018). https://doi.org/10.1007/s10384-018-0570-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10384-018-0570-0